Article Information
History
- April 24, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Kengo Matsumoto1,*,
- Tsutomu Nishida1,
- Satoru Okabe1,
- Naohiro Sakamoto1,
- Yoshifumi Fujii1,
- Naoto Osugi1,
- Aya Sugimoto1,
- Dai Nakamatsu1,
- Masashi Yamamoto1,
- Koji Fukui1,
- Osamu Morimura2,
- Kinya Abe2,
- Yukiyoshi Okauchi2,3,
- Hiromi Iwahashi2,3 and
- Masami Inada1
- 1Department of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, Osaka, 560–8565, Japan
- 2Department of Internal Medicine, Toyonaka Municipal Hospital, Toyonaka, Osaka, 560–8565, Japan
- 3Diabetes Center, Toyonaka Municipal Hospital, Toyonaka, Osaka, 560–8565, Japan
- ↵*Corresponding author:
Kengo Matsumoto, M.D. PhD Department of Gastroenterology, Toyonaka Municipal Hospital 4-14-1 Shibahara, Toyonaka, Osaka 560-8565 Japan Tel.: +81-6-6843-0101 Fax: +81-6-6858-3531 Email: ken5{at}gh.med.osaka-u.ac.jp; ken5mkg{at}gmail.com
Authors’ contributions: Kengo Matsumoto wrote the manuscript; and Tsutomu Nishida analyzed the data; Satoru Okabe, Naohiro Sakamoto, Yoshifumi Fujii, Naoto Osugi, Aya Sugimoto, Dai Nakamatsu, Masashi Yamamoto, Koji Fukui, Osamu Morimura, Kinya Abe, Yukiyoshi Okauchi, Hiromi Iwahashi, and Masami Inada provided medical care for the patients enrolled in this study and reviewed and edited the manuscript.
Posted April 24, 2024.
An increase in aspartate aminotransferase levels can predict worsening disease severity in Japanese patients with COVID-19
